Hirata (JP:6258)

:6258

6258

Hirata

RESEARCH TOOLSreports

Want to see JP:6258 full AI Analyst Report?

Hirata (6258) Price & Analysis

0 Followers

6258 Stock Chart & Stats

¥2415.00

-¥50.00(-0.91%)

At close: Jan 08 4:00 PM EST

¥2415.00

-¥50.00(-0.91%)

Day’s Range― - ―

52-Week Range¥1,776.00 - ¥3,755.00

Previous CloseN/A

Volume84.90K

Average Volume (3M)251.38K

Market Cap

¥99.50B

Enterprise Value¥103.45B

Total Cash (Recent Filing)¥10.65B

Total Debt (Recent Filing)¥36.77B

Price to Earnings (P/E)16.2

Beta1.74

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.68%

Share Statistics

EPS (TTM)169.64

Shares Outstanding32,268,270

10 Day Avg. Volume250,490

30 Day Avg. Volume251,383

Financial Highlights & Ratios

PEG Ratio0.41

Price to Book (P/B)0.94

Price to Sales (P/S)0.76

P/FCF Ratio5.53

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)218.14

Revenue Forecast (FY)¥97.18B

Bulls Say, Bears Say

Bulls Say

Consistent Revenue GrowthSteady multi-year revenue expansion to ~JPY 94.9B signals durable demand for Hirata’s FA systems and turnkey projects. Persistent top-line growth supports scale advantages in engineering, stable backlog conversion, and capacity to invest in product development and service capabilities over 2–6 months.

Stronger Balance SheetMaterial equity build and lower net debt improve financial flexibility, enabling Hirata to bid on larger turnkey contracts, absorb project timing swings, and fund selective capex without immediate external financing. A healthier capital structure reduces refinancing and covenant risks.

Recovery In Cash GenerationA clear cash-flow rebound with significant positive OCF and free cash flow improves self-funding capacity for working capital, maintenance capex, and debt repayment. Strong FCF over recent years enhances ability to sustain operations and strategic investments without dilutive financing.

Bears Say

Historic Cash-Flow VolatilityPeriods of negative OCF in 2022–2024 point to project-timing and working-capital swings typical in project-based FA businesses. This intermittency can strain liquidity, complicate forecasting, and raise the risk that cash conversion reverses during future project delays or order slowdowns.

Moderate And Variable MarginsProfitability improved but remains moderate and somewhat inconsistent year-to-year, limiting operating leverage. In a competitive industrial-machinery market, margin volatility reduces cushion against cyclical revenue dips and constrains reinvestment capacity and long-term margin expansion.

Prior Leverage Spike RiskA recent history of rising debt into 2024–2025 indicates the company can experience balance-sheet pressure during growth or timing mismatches. Although debt fell in 2026, recurrence of elevated leverage would limit flexibility and increase vulnerability to order postponements or adverse industry cycles.

Hirata News

Hirata to Divest Non-Core Subsidiary Trinity to Higo Bank

The latest announcement is out from Hirata ( ($JP:6258) ). Hirata Corporation will sell all shares in its...

27d ago

Hirata Lifts Earnings and Strengthens Balance Sheet, Signals Further Growth in FY2027

Hirata ( ($JP:6258) ) has shared an update. Hirata Corporation reported solid results for the fiscal year ended...

1M ago

Hirata Delivers Strong FY2026 Earnings and Targets Further Growth in FY2027

Hirata ( ($JP:6258) ) just unveiled an announcement. Hirata reported solid results for the fiscal year ended March...

1M ago

Hirata Reshapes Top Management as Leadership Shifts to New President

Hirata ( ($JP:6258) ) has shared an update. Hirata Corporation has announced a significant reshuffle of its top...

3M ago

Hirata boosts nine-month profits and maintains upbeat full-year outlook

Hirata ( ($JP:6258) ) has issued an announcement. Hirata reported consolidated net sales of ¥69.1 billion for the...

4M ago

Hirata Lifts Nine-Month Profit 60% and Confirms Full-Year Guidance

An announcement from Hirata ( ($JP:6258) ) is now available. Hirata reported solid growth for the nine months...

4M ago

HIRATA Corporation Announces Leadership Transition

An announcement from Hirata ( ($JP:6258) ) is now available. HIRATA Corporation announced a change in its executive...

8M ago

Hirata Corporation Reports Strong Financial Growth for 2025

Hirata ( ($JP:6258) ) has shared an update. Hirata Corporation reported significant financial growth for the six months...

8M ago

Hirata Corporation Continues Performance-Linked Stock Compensation Plan

Hirata ( ($JP:6258) ) has issued an announcement. Hirata Corporation has announced the continuation of its performance-linked stock...

11M ago

Hirata Corporation Reports Strong Q1 2025 Financial Results

Hirata ( ($JP:6258) ) just unveiled an update. Hirata Corporation reported a significant improvement in its financial performance...

11M ago

6258 FAQ

What was Hirata’s price range in the past 12 months?

Hirata lowest stock price was ¥1776.00 and its highest was ¥3755.00 in the past 12 months.

What is Hirata’s market cap?

Hirata’s market cap is ¥99.50B.

When is Hirata’s upcoming earnings report date?

Hirata’s upcoming earnings report date is Aug 06, 2026 which is in 45 days.

How were Hirata’s earnings last quarter?

Hirata released its earnings results on May 14, 2026. The company reported ¥44.85 earnings per share for the quarter, beating the consensus estimate of N/A by ¥44.85.

Is Hirata overvalued?

According to Wall Street analysts Hirata’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hirata pay dividends?

Hirata pays a Annually dividend of ¥74 which represents an annual dividend yield of 1.68%. See more information on Hirata dividends here

What is Hirata’s EPS estimate?

Hirata’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hirata have?

Hirata has 32,268,270 shares outstanding.

What happened to Hirata’s price movement after its last earnings report?

Hirata reported an EPS of ¥44.85 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.803%.

Which hedge fund is a major shareholder of Hirata?

Currently, no hedge funds are holding shares in JP:6258

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Hirata

Hirata Corporation, founded in Kumamoto, Japan, in 1920, is a global provider specializing in advanced industrial automation. The company designs, manufactures, and distributes a comprehensive range of production line systems, diverse industrial robots, and sophisticated logistics equipment. Its extensive product portfolio serves various industries, including: Automotive sector: Supplying assembly lines for engines (including cylinder heads and pistons) and transmissions (such as CVT, automatic, and DCT). Semiconductor manufacturing: Offering critical equipment like front-end modules, wafer handling robots, aligners, load ports, and SMIF openers. Flat panel display production: Delivering systems for coating, glass cutting, lamination, and automated loading. Robotics: Providing a wide array of industrial robots including Cartesian, SCARA-type, articulated, and wafer transfer robots, along with 3D vision systems, controllers, and simulation tools. Electronics and appliance assembly: Developing automated production lines for consumer electronics and other electrical components. Power module fabrication: Supplying specialized machinery such as mounters, vacuum reflow ovens, and ultrasonic welders. Intralogistics and production management: Offering sorting and stocking systems, stacker cranes, and traceability solutions. Medical and scientific research: Producing specialized devices for pathological tissue preparation, cell observation and destruction, and membrane damage detection.